RCM Vendor Savista Buys Oncology Data Services Company

Companies say the acquisition allows ONCO to focus on advancing its cancer registry software, while Savista enhances service delivery
Oct. 14, 2025
2 min read

Revenue cycle management (RCM) services company Savista has acquired the cancer registry services division of ONCO, a provider of oncology data services and technology. 

Savista has more than 800 clients across 49 states. By expanding cancer registry services alongside its suite of RCM solutions, Savista said it can offer healthcare organizations even greater end-to-end support in improving operational efficiency, enhancing compliance, and delivering better patient outcomes. Bundled offerings will now include cancer registry services, analytics, and consulting.

The combined organization now includes what Savista calls the largest pool of Oncology Data Specialists–Certified (ODS-Cs) in the industry.

The company said that while ONCO’s cancer registry services team transitions to Savista, ONCO will continue to own, operate, and fully support its technology platforms – including the ONCOLog Web Application (OWA), ONCOLog, and ONCONav. Savista added that the acquisition allows ONCO to focus on advancing its cancer registry software, while Savista enhances service delivery.

The combined companies are expected to lead to advancements in AI-driven case finding and abstraction workflows, enabling faster, more accurate data collection and improved return on investment for clients.

The acquisition also expands geographical coverage and eligibility for additional state contracts. Savista said multi-site health systems will benefit from scalable support, consolidated abstraction protocols and enhanced data standardization. 

“The transition of ONCO’s Professional Services team to Savista represents a strategic step forward for both organizations,” said Jim Hendrickson, Co-CEO of ONCO, in a statement. “Savista brings deep expertise in healthcare operations, and we are confident that our professional services colleagues will thrive as part of their team. This move allows ONCO to sharpen our focus on delivering innovative cancer registry software and AI-driven solutions, while ensuring our clients continue to receive the exceptional support and services they have come to expect.”

 

About the Author

David Raths

David Raths

David Raths is a Contributing Senior Editor for Healthcare Innovation, focusing on clinical informatics, learning health systems and value-based care transformation. He has been interviewing health system CIOs and CMIOs since 2006.

 Follow him on Twitter @DavidRaths

Sign up for our eNewsletters
Get the latest news and updates